The FRAILOMIC Initiative aims to provide useful tool kits for care providers that will allow them to assess the risk of an older individual developing frailty (i.e. ‘risk biomarkers’) as well its identification (i.e. ‘diagnostic bio- markers’), clinical course (i.e. ‘prognostic biomarkers’) and likely response to treatment (i.e. ‘predictive biomark- ers’), thus bridging the gaps between epidemiology and clinical practice.
Sourced through Scoop.it from: content.karger.com